Summary Safety Review - Alpha Lipoic Acid - Assessing the Potential Risk of Low Blood Sugar (Hypoglycemic Episodes)

This safety review was carried out by Health Canada after the publication of case reports of IAS (insulin autoimmune syndrome) causing hypoglycemic episodes linked with the use of oral alpha lipoic acid products in individuals with a genetic variation which causes the body's own defence system to attack insulin (insulin autoimmune syndrome).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-08

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data